Navigation Links
U.S., U.K. Stem Cell Banks to Team Up

Leaders of national embryonic stem cell banks in the United States and the United Kingdom pledged Monday to work together to promote //research, create international standards and more efficiently distribute each other’s cells.

The officials told reporters they hoped the efforts were the beginning of a long partnership between the National Stem Cell Bank in Madison and the U.K. Stem Cell Bank near London.

While stem cell research is in its early stages, scientists believe it may eventually lead to treatment and perhaps cures for diseases such as Parkinson’s and juvenile diabetes.

The government-funded U.K. bank opened in 2004 as a repository for stem cells derived from embryos and adults. Its American counterpart was created the following year at WiCell Research Institute, a nonprofit connected to the University of Wisconsin, under a federal contract.

The U.S. bank houses and distributes 13 of the 21 embryonic stem cell lines that can be used in federally funded research under President Bush’s policy limiting support to lines created before 2001. Wisconsin researcher James Thomson isolated the first of those lines in 1998.

Stem cells are created in the first days after conception. Because they go on to form the body’s tissues and cells, scientists say they could unlock the mystery of many diseases and one day lead to cures.

But some people oppose the research because days-old embryos — usually leftover from fertility treatments — are destroyed in the effort to isolate the cells.

The two banks said they would discuss international standards for how cells are ethically derived from human embryos and maintained.

'Our main focuses are very similar: We want to promote the research and the development of potential therapies in the future,' said Glyn Stacey, director of the U.K. bank. 'These are the kinds of issues we’re talking about, and trying to make appropriate cell lines available t o researchers and for clinical trials as well.'

Carl Gulbrandsen, president of WiCell, said the two would discuss joint distribution of each other’s cell lines. His group has already reached distribution agreements with some overseas companies.

'Shipping stem cell lines overseas is no easy task, hoping they arrive, they are healthy and can be used,' he said.

Source-Bio-Bio TechnologyBR>SRM
'"/>




Related medicine news :

1. U.S., Australian Scientists Develop Vaccine Against Deadly Viruses
2. Unpopularity of Sperm Banks...
3. FDA Approves Novel Test to Check Tainted Blood in Blood Banks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology: